Why Is UNH Stock Trading At A Premium With The Slowest Growth?
UnitedHealth (UNH) commands a higher stock price compared to its peers, despite generating slower revenue growth and margin. This premium is primarily attributed to its Optum business, which boasts higher margins and revenue growth than the rest of the company. UnitedHealth's Optum Rx pharmacy benefit arm is expected to generate over $6.25 billion in operating earnings by 2026, with management anticipating over 95% of clients to have full pass-through of manufacturer rebates.
The care delivery arm, Optum Health, serves 20 million individuals through various healthcare services. In 2026, management aims to increase its adjusted earnings per share guidance to a range of $19.50 to $20.00. However, the commercial book faces challenges, as medical cost trends exceed expectations and full commercial margin recovery is projected to take several years.
UnitedHealth is implementing measures to reduce costs, such as eliminating prior authorization requirements for a broad range of conditions. The stock's valuation reflects a margin lead expected from Optum, coupled with the slow growth of the overall group.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
